Malcolm Richardson is the Director of the Mycology Reference Centre, Manchester University NHS Foundation Trust at Wythenshawe Hospital and an honorary Professor of Medical Mycology at the University of Manchester. In 2017 the Mycology Reference Centre became the first European Confederation of Medical Mycology Centre of Excellence (Diamond Status). Malcolm Richardson is an elected Fellow of the Royal College of Pathologists and the Royal Society of Biology. His clinical and laboratory investigations have focused on the pathogenicity, diagnosis and epidemiology of superficial and systemic fungal infections. More recently he has applied his diagnostic experience to investigating the mycobiome of indoor environments using next generation sequencing.
He has published over 400 original articles, book chapters and reviews and is the author or editor of fifteen mycological textbooks and handbooks, including Fungal Infection in the Compromised Patient (1982, 1991), Medical Mycology - A Practical Approach (1989), Fungal Infection: Diagnosis and Management (1993, 1997, 2003, 2012), Therapeutic Guidelines in Systemic Fungal Infection (1998, 2001, 2003, 2007), The Pocket Guide to Fungal infection (2000, 2006), Fast Facts: Superficial Fungal Infections (2000) and Fungal Infection and Critical Care Medicine (2008). His h-index is 60. Malcolm Richardson is a frequent speaker and session chair at major international conferences in the fields of clinical microbiology, infectious diseases, and medical mycology. From 2008 to 2014 Malcolm Richardson was the Editor-in-Chief of Critical Reviews in Microbiology. Current editorial activities include being Reviews Editor for Medical Mycology. Malcolm Richardson was President of the International Society of Human and Animal Mycology (ISHAM), 2015 - 2018 and currently is the President of the Institute of Specialist Surveyors and Engineers (2013 - ). He is a senior advisor for the Global Action Fund for Fungal Infections (GAFFI) whose vision is to reduce illness and deaths associated with fungal disease worldwide.
· Mechanisms underpinning fungal disease and allergy in humans.
· Pathogenesis of candidosis
· Pathogenesis of aspergillosis
· New diagnostic platforms for the diagnosis of superficial and systemic fungal infections
· Development of point-of-care tests for the diagnosis of systemic fungal infections
· Improvements in the diagnosis of chronic forms of pulmonary aspergillosis
· Antifungal properties of reactive oxygen species
· Mycobiome of the built environment
Lucy has more than 20 years’ experience in the healthcare market. In the past 4 years I have focused on building a hospital service management business linking China with the UK. Lucy has rich experience for developing healthcare business. She understand the different business cultures and rules of China and the UK so she understand how to execute the healthcare project in China. ( https://www.linkedin.com/in/lucy-xu-macrae-013b9129/)
Qin Hai Yan
Qin has rich experience in healthcare market for the marketing plan and the lab operation business. Qin was VP in TOP-Gen and in charge of the strategy for the market and lead the BRCAS-China research in China.
Clinician on Hematology and Oncology, graduated from Sun Yat-sen University，Doctor of Molecular Medicine. In 2006, after achieved Master degree of Hematology, he engaged in clinical medicine teaching and research work in the Department of Hematology in the third affiliated hospital of Sun Yat-sen University, as the backbone of the hematopoietic stem cell transplantation team. After 2015, he has been engaged in the clinical transformation and academic work of molecular diagnostic technology in BGI Genomics and Kingmed Diagnostics Group.
Graduated from Huazhong Agricultural University in 2010, master's degree in microbial molecular biology. About 10-year experience in molecular laboratory management, served in production center and Shenzhen delivery center of BGI Genomics, rich experience in molecular experiments and NGS platform operation experience.